Urology News by Topic
Latest Urology News
Recurrence-free survival was 66 percent at five years for patients with bladder cancer who had laparoscopic radical cystectomy.
Patients with these tumors should be counseled appropriately and offered treatment options for intermediate-risk disease.
NBI visualized non-muscle-invasive bladder cancer lesions in 17% more patients and 24% more tumors than white light.
PSA doubling time of 6 months or less and seminal vesicle invasion were significant predictors of biochemical recurrence.
Prevalence of premature ejaculation was similar for all young males with or without type 1 diabetes mellitus, however.
In a study, the treatment was used in men who experienced prostate cancer recurrence after primary radiotherapy.
New study links statin use with a 52% improvement in 3-year disease-specific survival.
In a placebo-controlled study, 57% of men unable to have intercourse were able to do so without medication after receiving the treatment.
A study of 4,803 patients who underwent robot-assisted radical prostatectomy had long-term outcomes on par with other surgical approaches.
Long-term testosterone therapy in hypogonadal men is safe, an observational study suggests. New cases of prostate cancer were lower than expected.
Most men aged 66 to 79 years receive aggressive treatment even though their life expectancy is less than 10 years.
For Caucasian males, a complete family history of prostate cancer among close and distant relatives may gauge personal risk with greater accuracy.
New study examined the effect of a U.S. Preventive Services Task Force 2012 recommendation against routine PSA screening.
It preserves kidney function better than radical nephrectomy in patients with small- to medium-sized tumors, study finds.
Increased likelihood of testing in men with comorbidity associated with hypogonadism.
Article describes challenges for women in medicine, highlights things that need to be changed.
Men with asymptomatic vascular disease are more likely to develop erectile dysfunction (ED) compared to those who don't.
Prostate cancer (PCa) patients who have the Endo180 protein present in their tumors tend to have a more aggressive form of the disease.
Obese men are at a greater risk of developing more advanced forms of prostate cancer (PCa).
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)